Announced Fri, 24 Jul · 17:36 IST
Board clears FY26 results, subsidiary plan, pharma expansion
Revenue Growth 20pctPat Growth 25pctEmphasis Of MatterRelated Party TransactionsNegative Operating CashflowResults View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Board approved FY26 consolidated results with revenue up 51 percent to Rs 14,758 lakhs and profit up 73 percent to Rs 535 lakhs, with an unmodified auditor opinion. Also approved subsidiary incorporation, pharma expansion, AGM on 21 Aug 2026, and deferred termination of Astonea One agreements. Auditor flagged a Rs 9.39 crore fire loss and Rs 41.40 crore related party sales.
Likely market impact
Strong revenue and profit growth, clean audit opinion. Fire loss and related party deals flagged but not impacting going concern status.